Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127854) titled 'Development and Validation of a Prognostic Model Incorporating Pan-Immune-Inflammation and Nutritional Indicators for Extranodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study' on July 8.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Extranodal NK/T-cell lymphoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-22
Target Sample Size: Observation group:204;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=331764
Pu...